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Summary. Background: The YEARS algorithm was designed to simplify the diagnostic work-up of pulmonary embolism (PE) and to reduce the number of necessary computed tomography pulmonary angiography (CTPA) scans. An alternative strategy to reduce the number of CTPAs is the age-adjusted D-dimer cut-off (ADJUST) in patients aged 50 years or older. We aimed to investigate whether a combination of both diagnostic strategies might save additional CTPAs. Methods: The YEARS algorithm consists of three items (clinical signs of deep venous thrombosis, hemoptysis, 'PE most likely diagnosis') with simultaneous D-dimer testing using a pre-test dependent threshold. We performed a post hoc analysis in 3465 patients managed according to YEARS to compare the number of patients managed without CTPA scans and associated diagnostic failures in hypothetical scenarios with different YEARS-ADJUST combinations. Results: Following the YEARS algorithm, 1651 patients (48%) were managed without CTPA; PE was diagnosed in 456 (13%) patients at baseline and 18 patients with initial normal testing suffered venous thromboembolism (VTE) during 3-month follow-up (failure rate 0.61%; 95% confidence interval [CI], 0.36-0.96). If ADJUST had been fully integrated in YEARS,
Introduction
In patients with clinically suspected pulmonary embolism (PE), a fast and accurate diagnosis is mandatory to initiate anticoagulant treatment without delay in those patients with confirmed disease and to withhold such treatment in patients in whom the disease is ruled out.
The diagnostic process of PE is, however, challenging because of the non-specific and highly variable clinical presentation of PE. Routine use of clinical decision rules and the D-dimer test is therefore an important step in the standardized diagnostic approach for patients with suspected PE, because these assist in separating patients who need to be referred for imaging tests from those in whom PE can be ruled without further tests [1] .
D-dimer testing has a high sensitivity for venous thromboembolism (VTE). The majority of patients, however, still require imaging tests because of its low specificity. In elderly patients the D-dimer test is even less specific than in younger patients because of a steady rise of the D-dimer with aging [2] [3] [4] . To further decrease the number of required imaging tests in the diagnostic workup of suspected PE, two novel diagnostic strategies have been suggested and validated [5, 6] . The first strategy involves an age-adjusted D-dimer threshold in patients aged 50 years or older (ADJUST), defined as patients' age 9 10 ng/mL (Fig. 1D) [2, 5] . With this strategy, the number of patients aged 50 years or older in whom PE could be safely ruled out without imaging increased from 25% to 35% without an increase in the number of missed diagnoses at baseline, for a reported 3-month failure rate of 0.3% (95% confidence interval [CI], 0.1-1.7) [5] .
The second strategy is the YEARS algorithm, which was designed to simplify the diagnostic strategy in patients with suspected PE as well as to reduce the number of required computed tomography pulmonary angiographies (CTPAs) (Fig. 1A) [7]. According to YEARS, patients are managed by simultaneous assessment of the D-dimer concentration and the three YEARS items ('clinical signs deep venous thrombosis', 'hemoptysis' and 'PE most likely diagnosis'). In patients without YEARS items and a D-dimer level below 1000 ng mL À1 , as well as in patients with one or more YEARS items and a D-dimer level below 500 ng mL À1 , PE is considered to be ruled out without the need for further imaging. A recent management study demonstrated an increase in the proportion of patients managed without CTPA from 34% to 48%, for an absolute difference of 14% compared with the conventional strategy in all age categories, with a low 3-month failure rate of 0.61% (95% CI, 0.36-0.96) [6] . We hypothesized that the combination of ADJUST and YEARS could potentially further improve the efficiency of the diagnostic work-up of patients with suspected PE. We therefore set out to analyze the number of patients managed without CTPA and diagnostic failures in hypothetical scenarios with different YEARS-ADJUST combinations.
Methods

Study population
This is a post hoc analysis of the prospective YEARS study [6] . All patients were managed according to the YEARS algorithm (Fig. 1A) . Consecutive in-and outpatients with clinically suspected PE were included if they were 18 years or older. Exclusion criteria were pregnancy, life expectancy less than 3 months, geographic inaccessibility precluding follow-up, treatment with therapeutic doses of anticoagulants initiated ≥ 24 h prior to eligibility assessment and allergy to intravenous contrast agents. All patients were followed for 3 months for the occurrence of symptomatic recurrent or fatal VTE.
Primary aim
We studied the outcome of the algorithm in four different scenarios: (i) the YEARS algorithm, which was used to prospectively manage all patients; (ii) a hypothetical scenario with age-adjusted D-dimer threshold for patients aged ≥ 50 years and one or more YEARS items, with all other patients managed according to YEARS; (iii) a hypothetical scenario with age-adjusted D-dimer threshold for all patients aged ≥ 50 years and with all patients younger than 50 years managed according to YEARS; and (iv) all patients managed according to the conventional algorithm (i.e. using the Wells clinical decision rule, with age-adjusted D-dimer threshold for patients aged ≥ 50 years and a D-dimer threshold of 500 ng mL À1 for patients younger than 50 years) (Fig. 1A , B, C and D). For all our scenarios, we assumed that patients would have been referred for CTPA when the D-dimer was above the predefined threshold and PE would have been considered ruled out in patients with a D-dimer below that threshold. The YEARS algorithm is detailed in Fig. 1 (A). For the second and third scenario, the age-adjusted D-dimer threshold was calculated for all patients of 50 years and older. In the second scenario, we evaluated the endpoints of this study as if all patients of 50 years and older with one or more YEARS items were managed according to ADJUST (Fig. 1B) . For the third scenario, we evaluated the endpoints of this study as if all patients younger than 50 years were managed according to the D-dimer threshold of the YEARS algorithm and all patients of 50 years and older according to ADJUST (Fig. 1C) . To investigate the fourth scenario (full ADJUST algorithm), the complete Wells score was calculated for all patients to assess the clinical probability of PE (Fig. 1D ). All items of the Wells score were prospectively assessed in the study at baseline for post hoc analyses. Patients aged 50 years or older were managed according to the age-adjusted D-dimer cut-off and patients younger than 50 years according to the predefined threshold of 500 ng mL
À1
. Lastly, we predefined a subgroup analysis restricted to patients aged 50 years or older for all four scenarios.
If more patients had been referred for CTPA in scenarios 2, 3 and 4, it is important to keep in mind that these CTPAs were not performed and the results of these scans, which could have detected additional PE cases, remain unknown.
Endpoints
Our safety endpoint was the failure rate of the algorithm (i.e. the number of missed PE diagnoses at baseline and recurrent or fatal VTE during the 3-month follow-up for all scenarios). The efficiency endpoint was the proportion of patients managed without CTPA.
Statistical analysis
An absolute difference with 95% confidence interval between the different scenarios was calculated to compare the proportion of patients managed without CTPA and the failure rate of the four scenarios. All analyses were performed using SPSS, version 23.0 (Chicago, IL, USA).
Results
Patient characteristics
Between October 2013 and July 2015, 3465 consecutive patients were included in the YEARS study in 12 hospitals in the Netherlands [6] . The mean age of these patients was 53 years, 62% were female patients and 42% of the patients were above the age of 50 years (Table 1) . PE was diagnosed in 456 patients for an incidence of 13%. Contraceptive use was registered in 10% of the patients, 10% of all patients were familiar with prior VTE and 12% were immobilized or underwent surgery in the last 4 weeks.
Scenario 1: YEARS algorithm
In the YEARS study, 1651 patients (48%) were managed without CTPA, of whom 1319 patients were in the group without YEARS items and 332 patients in the group with one to three YEARS items. Pulmonary embolism was diagnosed in 456 patients (13%). During the 3-month follow-up period, nine patients with an initial negative ruling by the algorithm who remained untreated were diagnosed with VTE and PE could not be ruled out as cause of death in six additional patients. Furthermore, PE was diagnosed in three patients at baseline on CTPA that was not indicated, for a total failure rate of 18/2946 (0.61%; 95% CI, 0.36-0.96) ( Table 2 ) [6] .
Scenario 2: Implementing ADJUST into the YEARS algorithm in patients with one or more YEARS items
If the age-adjusted D-dimer threshold had been only applied in those patients with at least one YEARS item, 1747 patients (50%) could have been managed without CTPA, for an absolute difference of 2.8% (95% CI, 0.42-5.1) compared with YEARS. This higher proportion of patients managed without CTPA in this scenario corresponded to a projected failure rate of 0.75% (22/2946; 95% CI, 0.5-1.1), because of four patients with a PE that would have been missed at baseline (Table 2 ).
Scenario 3: Implementing ADJUST into the YEARS algorithm in all patients
If the age-adjusted D-dimer cut-off had been used in all patients, 1627 patients (47%) would have been managed without CTPA, an absolute decrease of 0.69% (95% CI, À1.7 to 3.0) lower than YEARS (Table 2 ). Four patients with one to three YEARS items and a D-dimer below the age-adjusted threshold with a confirmed PE would have been missed, resulting in a projected 3-month VTE failure rate of 0.75% (22/2946; 95% CI, 0.5 to 1.1).
Scenario 4: ADJUST
If the full Wells clinical decision rule had been applied with the age-adjusted D-dimer threshold for patients of 50 years or older, 1348 patients (39%) could have been managed without CTPA at baseline, an absolute 8.7% (95% CI, 6.4-11) decrease in comparison to YEARS. According to ADJUST, two patients with PE at baseline would have been missed because of low clinical probability and a D-dimer below the age-adjusted threshold. During 3 months follow-up, 10 patients would have been diagnosed with VTE and PE could not be excluded as cause of death in six patients. On the other hand, two patients diagnosed with PE at baseline by protocol violation in YEARS, had a D-dimer above the age-adjusted threshold and would therefore have been referred for CTPA by the ADJUST algorithm. Taken together, the projected 3-month VTE failure rate would therefore have been 0.61% (95% CI, 0.36-0.96) ( Table 2) . Table 3 ). In scenario 2, the absolute difference in patients managed without CTPA would have been 4.7% (95% CI, 1.7-7.7) higher. This significant difference came at a cost of a 3-month failure rate of 1.2% (20/1642; 95% CI, 0.79-1.9) ( Table 3 ). In scenario 3, 1.2% (95% CI, À1.8 to 4.2) fewer patients could have been managed without CTPA than in YEARS, at a cost of a 3-month failure rate of 1.2% (20/1642; 95% CI, 0.79-1.9). Lastly, if the ADJUST strategy had been used, 5.2% (95% CI, 2.3-8.1) fewer patients could have been managed without CTPA than in YEARS, at a cost of a 3-month failure rate of 0.97% (16/1642; 95% CI, 0.60-1.6).
Discussion
In this post hoc analysis of the YEARS study we found no added value of implementing ADJUST in the YEARS algorithm in different scenarios studied, as well as among the subgroup of patients older than 50 years. Only the scenario in which the age-adjusted D-dimer threshold was implemented in patients of 50 years and older with at least one YEARS item (scenario 2) was associated with a projected significant further decrease in the number of required CTPA scans, at a cost of four missed PE diagnoses at baseline. Imaging is warranted to confirm or rule out the diagnosis of PE when the D-dimer is above the threshold in patients with suspected PE. The associated exposure to radiation, the risk of contrast-induced nephropathy, the potential for over-diagnosis and the associated costs of radiological tests are important reasons to limit the number of required scans to a minimum [8] . Einstein et al. studied the lifetime attributable risk of cancer associated with radiation exposure. This study demonstrated an unneglectable lifetime attributable risk of cancer varying from 0.075% to 0.70%, with the highest risk in women and in younger patients. The highest lifetime risk of cancer was for lung and breast cancer [9] . Mathews et al. performed a large population-based cohort study to assess the risk of cancer following exposure to radiation from diagnostic CT scans. The overall incidence of cancer was 24% higher after exposure to radiation compared with unexposed people [10] . The incidence of contrast-induced nephropathy varies between 2.6 and 14% after CTPA for suspected PE [11] [12] [13] [14] . Kooiman et al. demonstrated in a retrospective analysis that age over 75 years is an independent predictor for contrast-induced nephropathy, as are multiple myeloma, use of non-steroidal anti-inflammatory drugs (NSAIDs) and diabetes mellitus [13] . With increased utilization of CTPA, the incidence of other adverse reactions to iodinated contrast media has increased as well. For instance, the incidence of hypersensitivity reactions has been estimated to be between 0.1 and 0.6% of patients injected with non-ionic iodinated contrast media [15, 16] . The majority of hypersensitivity reactions are mild, but the less frequent moderate and severe reactions may be life threatening [17] .
Based on previous studies [18] , we hypothesized that combining the age-adjusted threshold with the YEARS algorithm would be associated with a further reduction in the number of CTPAs in elderly patients. Our hypothesis was, however, rejected by the results of this study, with similar findings across almost all scenarios and in the subgroup analysis of patients aged 50 years or older. Only in scenario 2, was the proportion of patients managed without CTPA higher, with an absolute difference of 4.7% (95% CI, 1.7-7.7) compared with YEARS. Even so, this reduction of CTPAs came at a cost of four additional failures, with missed diagnosis of PE at baseline, which is in our opinion an unacceptably high failure rate to save this limited number of CTPAs. Moreover, implementing scenario 2 in a busy clinical practise would introduce a large amount of complexity into the YEARS algorithm, which was designed to simplify the diagnostic work-up of patients with suspected PE. Prior studies demonstrated poor adherence of clinicians to pre-test probability rules and following algorithms, with an even higher risk of inappropriate management in patients older than 75 years [19, 20] . Use of the age-adjusted D-dimer cut-off only in patients of 50 years and older with at least one YEARS item will likely to increase the risk of inappropriate management of patients with suspected PE, compromising the safety of the algorithm.
The main strength of our study is the inclusion of a large number of consecutive in-and outpatients with suspected PE. Data were prospectively collected and all events during follow-up were adjudicated by an independent committee. Moreover, we studied the potential improvement of the algorithm in different scenarios.
The main limitation of this post hoc analysis is that patients were not randomized between the four studied strategies. Only patients with a D-dimer above the established threshold of YEARS were referred for CTPA. Hence, we could not directly compare the results of the scenarios. For this reason, it is not known if all diagnosed PEs that would have been missed in the different scenarios were clinically relevant (i.e. that the relevant patients indeed would have benefited from treatment with oral anticoagulants). Vice versa, it is not known whether the extra CTPA scans that would have been made in the different scenarios would not have shown additional PEs. Even so, we consider the low risk of events during the study followup as a strong argument that important PE diagnoses were not missed by the YEARS algorithm. Moreover, these post hoc analyses were performed without a sample size calculation and may have been underpowered. Therefore, our findings should be regarded as hypothesis generating. Nevertheless, our findings do not justify a prospective study to find a more definite answer to our research question. The second limitation is the somewhat lower incidence of PE in the YEARS study compared with other European studies, although our subgroup analysis in patients of 50 years and older demonstrated a low failure rate despite the higher incidence of PE of 16% in this group.
In conclusion, there was no added value of implementing ADJUST in the YEARS algorithm in our cohort. Reduction in the proportion of patients managed without CTPA was only found in scenario 2, although at the unacceptable cost of four additional diagnostic failures. In our cohort both for patients under 50 years and those over the age of 50 years, YEARS was associated with the most beneficial safety and efficiency profile of all the studied diagnostic scenarios.
